Genprex, Inc. (GNPX)
NASDAQ: GNPX · Real-Time Price · USD
7.67
-0.33 (-4.13%)
At close: Jul 17, 2026, 4:00 PM EDT
7.45
-0.22 (-2.87%)
After-hours: Jul 17, 2026, 7:58 PM EDT
Genprex Market Cap
Genprex has a market cap or net worth of $3.69 million as of July 17, 2026. Its market cap has decreased by -54.43% in one year.
Market Cap
3.69M
Enterprise Value
-14.36M
1-Year Change
-54.43%
Ranking
Category
Stock Price
$7.67
ChartMarket Cap Chart
Since March 29, 2018, Genprex's market cap has decreased from $11.40M to $3.69M, a decrease of -67.62%. That is a compound annual growth rate of -12.70%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 17, 2026 | 3.70M | -7.50% |
| Dec 31, 2025 | 4.00M | -44.44% |
| Dec 31, 2024 | 7.20M | -47.45% |
| Dec 29, 2023 | 13.70M | -80.32% |
| Dec 30, 2022 | 69.60M | 11.00% |
| Dec 31, 2021 | 62.70M | -61.84% |
| Dec 31, 2020 | 164.30M | 3,121.57% |
| Dec 31, 2019 | 5.10M | -69.28% |
| Dec 31, 2018 | 16.60M | 45.61% |
| Mar 29, 2018 | 11.40M | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Alzamend Neuro | 4.60M |
| FibroBiologics | 4.51M |
| Ensysce Biosciences | 4.16M |
| 60 Degrees Pharmaceuticals | 4.02M |
| Artelo Biosciences | 4.01M |
| Galmed Pharmaceuticals | 3.60M |
| Propanc Biopharma | 3.39M |
| GeoVax Labs | 3.38M |